Gibson Molly K, Pesesky Mitchell W, Dantas Gautam
Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Biomedical Engineering, Washington University, St. Louis, MO 63130, USA.
J Mol Biol. 2014 Nov 25;426(23):3866-76. doi: 10.1016/j.jmb.2014.05.029. Epub 2014 Jun 6.
The human gut is home to trillions of microbes that form a symbiotic relationship with the human host. During health, the intestinal microbiota provides many benefits to the host and is generally resistant to colonization by new species; however, disruption of this complex community can lead to pathogen invasion, inflammation, and disease. Restoration and maintenance of a healthy gut microbiota composition requires effective therapies to reduce and prevent colonization of harmful bacteria (pathogens) while simultaneously promoting growth of beneficial bacteria (probiotics). Here we review the mechanisms by which the host modulates the gut community composition during health and disease, and we discuss prospects for antibiotic and probiotic therapy for restoration of a healthy intestinal community following disruption.
人类肠道是数万亿微生物的家园,这些微生物与人类宿主形成共生关系。在健康状态下,肠道微生物群为宿主提供诸多益处,并且通常能抵御新物种的定植;然而,这种复杂群落的破坏会导致病原体入侵、炎症和疾病。恢复和维持健康的肠道微生物群组成需要有效的治疗方法,以减少和预防有害细菌(病原体)的定植,同时促进有益细菌(益生菌)的生长。在此,我们综述宿主在健康和疾病状态下调节肠道群落组成的机制,并讨论在肠道群落遭到破坏后,使用抗生素和益生菌疗法恢复健康肠道群落的前景。